What Changed at AIRS Medical

Every material change AI Health Index has tracked at AIRS Medical: new modules, model and architecture updates, clinical evidence, regulatory status, security certifications, and integration depth. Each entry states what changed, cites its source, and carries our read on what it means for a buyer. The graded assessment of this vendor across all fifteen capability axes sits on its index profile.

Funding rounds, valuations, and awards are not product changes and are not logged here. Acquisitions appear only where there is direct product impact.

Follow this change log by RSS

Free for your reader, newsletter or automation tool. One feed covers the whole index, and every category has its own.

All feeds and terms

Impact

Type

1 entry

Showing changes for AIRS Medical only.Show the full log

October 2026

A

AIRS Medical

Oct 5, 2026

HighVerified

Regulatory / FDA

AIRS Medical received FDA 510(k) clearance for SwiftSight Body Composition, which measures visceral and subcutaneous fat, abdominal and thigh muscle, muscle quality and balance, and liver fat from an MRI scan of under five minutes. Results are benchmarked against age and sex matched reference populations in a single report, and SimonMed Imaging will be the first customer. It takes the SwiftSight platform beyond brain imaging, with diffusion tensor imaging planned for November 2026.

Our read

Imaging groups can add a body composition service on MRI scanners they already run, with no new modality and no manual measurement. Because MRI uses no radiation, repeat scans to track change over time are practical.

Related axis: FDA and Regulatory StatusVendor announcementView source